Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infection.
Gyu Young PihKee Don ChoiEun-Jeong GongHee Kyong NaJi Yong AhnJeong Hoon LeeKee Wook JungDo Hoon KimHo June SongGin Hyug LeeHwoon Yong JungPublished in: Helicobacter (2020)
Twice-a-day modified BQT-2 regimen with low-dose metronidazole was suboptimal as an alternative first-line therapy for eradicating H pylori, despite high patient compliance.